TropIQ Health Sciences

TropIQ Health Sciences is a biotechnology company that provides a technology platform for the discovery and development of interventions against vector-borne and insect-borne diseases. Based in Nijmegen, the Netherlands, the company combines expertise in microbiology, parasitology, and entomology with laboratory automation, data science, and machine learning. Their platform enables high-throughput screening and the identification of small molecules and biological candidates to combat pathogens such as those causing malaria, dengue, and tick-borne diseases. By integrating molecular, genetic, and cell biological technologies, TropIQ supports the optimization of lead molecules and the investigation of their mechanisms of action.

The company serves as a partner in global health efforts, focusing on interventions that address diseases affecting humans and animals, particularly in low and middle-income countries. TropIQ offers contract research services that span from assay development and parasite biomass production to in vivo arthropod testing and the evaluation of novel repellents. As a spin-off from Radboudumc, the company has received support from organizations including the Bill & Melinda Gates Foundation to advance agricultural and public health research, such as developing systems to combat livestock ticks and identifying innovative drugs and vaccines to mitigate the impact of disease-transmitting arthropods.